A further study has shown the potential of a treatment strategy by induction of an endogenous regulator against MAC, peroxisome proliferator-activated receptor-gamma coactivator-1 alpha in a CKD rat model [38]. The gene discussed is PPARGC1A; the disease is chronic kidney disease.